As shown in Fig. 4C, combination treatment dramatically suppressed the tumor growth in the MC38 tumor xenografts with an inhibition rate of 81.3% (CGA + Anti-PD-1 vs. NS + IgG, n = 7, p < 0.01). This evidence concerns the gene PDCD1 and neoplasm.